This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.
The drug CLAMOXIN contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
804826J2HU - AMOXICILLIN
|
|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
2
|
UNII
Q42OMW3AT8 - CLAVULANATE POTASSIUM
|
|
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-3305 | Tablet | Clamoxin 625 Tablets TAB 500 mg; 125 mg | Film-coated tablet. White or off white oval shaped film-coated tablets | 02/12/2021 |
| B4-5174 | Tablet | Clamoxin 375 Tablet TAB 250 mg; 125 mg 3 x 7's (in Alu-Alu blisters) | Film-coated tablet. White to off white colored, elongated, biconvex, film-coated tablet, plain on both sides. Free from any obvious defects | 02/12/2021 |
| C4-0148 | Powder for injection | Clamoxin 1200 Injection INJ_PWD 1000 mg; 200 mg 1.2 g x 1's (in clear glass vial) + 10 mL SWFI (in ampoule) | Powder for solution for injection in a vial | 31/07/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| HK | Department of Health Drug Office | 56268, 56453, 59166 |
| NG | Registered Drug Product Database | A4-3305, B4-5174, C4-0148 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.